Novelties in the field of parenteral cephem antibacterials since 1993

Bibliography

• BRYSKIER A, ASZODI J, CHANTOT JF: Parenteral cepha-losporin classification. Exp. Opin. Invest Drugs (1994) 3:145–171.
   Google Scholar
• NOMURA S, HANAKI II, FURUKAWA T, UNEMI N: Antibac-terial activity of TOG50, a new parenteral cepha-losporin against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. Chemo-therapy (Basel) (1997) 43:1–5.
   PubMed Web of Science ®Google Scholar
• NOMURA S, HANAKI H, UNEMI N: In vitro antibacterialactivity of TOC-50, a new parenteral cephalosporin against Methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Chemotherapy (Basel) (1996) 42:253–258.
   PubMed Web of Science ®Google Scholar
• HANAKI H, AKAGI H, OTANI T, HYODO A: Structure-ac-tivity relationship of a new cephalosporin with potent activity against methicillin-resistant S. aureus (MRSA). 35th Interscience Conference on Antimicrobial Agents and Chemotherapy San Francisco (1995) F60:123.
   Google Scholar
• HANAKI H, AKAGI H, MASARU Y et al: TOC-39, a novel parenteral broad spectrum cephalosporin with excel-lent activity against Methicillin-resistant S. aureus. An-timicrob. Agents Chemother. (1995) 39:1120–1126.
   PubMed Web of Science ®Google Scholar
• TAMURA A, MIYATA A, ISHI T et al.: CP 6,679, a new injectable cephalosporin. In vitro antibacterial activity. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco (1995) F45:120.
   Google Scholar
• TAMURA A, ISHI, T, MITANI N et al: CP 6,679 a new injectable cephalosporin. In vivo antibacterial activity. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco (19950 F45:120.
   Google Scholar
• HARA R, ITAHANA H, HISAMICHI H, FUKUOKA S, NA-GANO N: Synthesis and biological activity of new cephem compounds with a 3-(2-lbuteny0- and a 3-0,3 butadieny0 group at the 3' position. J. Antibiot. (1996) 49:1179–1185.
   PubMed Web of Science ®Google Scholar
• HARA R, SAKAMOTO K, HISAMICHI H, NAGANO H: Struc-ture-activity of cephalosporins having a (di-methylisoxazolidinio)vinyl moiety at the 3-position. Antibiot (1996) 49:1162–1171.
   Google Scholar
• HARA R, ITAHANA H, SAKAMOTO K, HISAMICHI H, NA-GANO N: Cycloadditi on reactions of a 341,3 butadieny0 cephalosporins and antibacterial activity of new ce phems derivatives .j Antibiotics (1996) 49:11862–1185.
   Google Scholar
• HARA R, SAKAMOTO K, ITAHANA H et al.: YM-40220, a new parenteral cephalosporin: synthesis and structure activity relationship of 342,2 dimethy1-5-isoxazolid-inio)vinyl cephalosporins. 34th Interscience Conference on Antimicrobi a I Agents and Chemotherapy Orlando (1994): F103.
   Google Scholar
• ARAO N, HIRANO S, KITAZAKI T et al.: YM-40220, a newparenteral cephalosporin - in vitro antibacterial activ-ity. 34th Interscience Conference on Antimicrobial Agents and Chemotherapy Orlando (1994):F105.
   Google Scholar
• WATANABE M, NAKAMURA Y, IWAI T eta].: YM-40220, anew parenteral cephalosporin - In vivo antibacterial activity. 34th Interscience Conference on Antimicrobial Agents and Chemotherapy.Orlando (1994):F107.
   Google Scholar
• OHKI H, KAWUBATA K, OKUDA S, KAMINURA T, SAKANEK: Studies on 3'-quaternary ammonium cephalosporins II - synthesis and antibacterial activity of 713- KC-7)-2-(2-aminothiazol-4-y0-2-methoxy aminoacetamido] cephalosporin derivatives bearing various quarternary ammonium methyl groups at the 3 position. J. Antibiotics (1995) 48:1049–1051.
   PubMed Web of Science ®Google Scholar
• OHKI H, KAWUBATA K, OKUDA S, KAMIMURA T, SAKANE K: FK 037, a new parenteral cephalosporin with a broad antibacterial spectrum: synthesis and antibacterial ac-tivity. J. Antibiot (1993) 46:359–361.
   PubMed Web of Science ®Google Scholar
• JUNG JC, KIM MG, SUNG MJ eta].: Synthesis and activity of benzotriazolium cephalosporins. J. Antibiot. (1995) 39:530–531.
   Google Scholar
• CHOI KH, KIN DJ, SHIM JS: In vitro and in vivo activity of DWC-751, a new cephalosporin. J. Antimicrob. Chemother. (1994) 33:1233–1237.
   PubMed Web of Science ®Google Scholar
• SMITH PW, CHAMIEC AJ, CHUNG G eta].: Synthesis and biological activity of novel cephalosporins containing a (a-vinyl dimethylphosphonate group. J. Antibiot. (1995) 48:73–82.
   Google Scholar
• ASZODI J, BONNEFOY A, CHANTOT JF eta].: Structure-ac-tivity relationship in a series of catechol-substituted vinylogous cephalosporins: fluoro derivatives with well-balanced antibacterial spectrum. 35th Interscience Conference on Antimicrobial Agent Chemotherapy. San Fran-cisco (1995):F95.
   Google Scholar
• ERWIN ME, JONES RN: In vitro activity of RU 59863, a new catechol containing cephalosporin antimicrobial agent. 36th Interscience Conference on Antimicrobial Agents Chemotherapy. New Orleans (1996):F145.
   Google Scholar
• FRÉMEAUX A, SISSIA G, BRYSKIER A, GESLIN P: In vitro activity of cefpirome and six other parenteral fl-lactam agents, penicillin-susceptible and penicillin-resistant pneumococci. Program and Abstracts of 35th Interscience Conference on Antimicrobial Agent Chemotherapy. San Fran-cisco (1995):F59.
   Google Scholar
• LE NOC P, BRYSKIER A, CHAMPEVALIER D: Comparative antibacterial activity of RU 59863 a new catechol cepha-losporin, and new C-3' quaternary ammonium cepha-losporins. 35th Interscience Conference on Antimicrobial Agent Chemotherapy San Francisco (1995):F59.
   Google Scholar
• OH JI, PAEK KS, SONG HK et al.: LB 10522, a newcatechol-substituted cephalosporin-I. In vitro and in vivo antibacterial activities. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy San Francisco (1995) F41:120.
   Google Scholar
• KIM MY, SONF HK, OH JI etal.: LB 10522, a new catechol-substituted cep halosporin-II. ii-lactarnase stabilities and biological activities. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco (1995) F41:120.
   Google Scholar
• ANGEHNR P, FURTENMEIER A, HEBEISEN P: Antipseudo-monal activity, in vitro and in vivo of Ro 44–3949, a cephalosporin bearing two catechol units. 35th Inter-science Conference on Antimicrobial Agent Chemotherapy. San Francisco (1995).
   Google Scholar
• TSUJI K, YASUMURA K, ISHIKAUWA H Synthesis and antibacterial activity of cephalosporins haing C-3 catechol- containing (pyridinium-4Thio)methyl groups. Bio. Org Med. Chemiett (1995) 5:963–966.
   Web of Science ®Google Scholar
• OBI K, SAITO, T, FUKUDA II, KIRAI K, SUZUC S: Novel cephalosporins having a benzothiopryan group. Syn-thesis and antibacterial activity by cephalosporin de-rivative characterised by novel C-3 substituent of benzothiopyran. j Antibiot (1995)48:274–277.
   Google Scholar
• KIM YZ, LIM JC, YEO JH et al: Synthesis and antimicrobial activity of novel 3-[(aminopyrimidiniumyllthio]methyl cephalosporins. J. Med. Chem. (1994) 37:3828–3833.
   PubMed Web of Science ®Google Scholar
• KIM YJ, YEO JH, UM JC: Synthesis and antibacterial activity of novel catechol-substituted cephalosporins. 34th Interscience Conference on Antimicrobial Agent Chemo-therapy. Orlando (1994). Abstract 609.
   Google Scholar
• KWAK JH, KIM SI, OH JI: In vitro and in vivo activities of LK 10517, a novel catechol substituted cephalosporin. 34th Interscience Conference on Antimicrobial Agent Chemo-therapy. Orlando (1994). Abstract 610.
   Google Scholar
• OBI K, SHIGA F, KOJIMA A, FUKUDA H, HIRAI K: AM-1817 and AM 1732, novel hydroxypyridone cephalosporins: synthesis and biological activities. 36th Intel-science Con-ference on Antimicrobial Agents and Chemotherapy New Orleans (1996):F143.
   Google Scholar
• OBI K, KOJIMA A, FUKUDA H, HIRAI K: Synthesis and biological activity of a novel class of cephalosporins with a oxadiazolyl hydroxypyridone moiety at C-7. [letter]. Bio. Org. Med. Chem.Lett. (1995) 5:2777–2782.
   Web of Science ®Google Scholar
• OBI K, SAITO T, KOJIMA A et al: Novel cephalosporin having a benzothiopyran group. Synthesis and biologi-cal activity of catecholic benzothiopyran group at the C-3 side chain. J. Antibiot (1995) 48:278–281.
   Google Scholar
• CHANG MH, KOH NY, CHO YS: New substituted pyridone type cephalosporins: synthesis and antimicrobial prop-erties. 34th Interscience Conference on Antimicrobial Agents and Chemotherapy Orlando (1994):F 109.
   Google Scholar
• KAMACHI H, OKA M, NARITA Y et al: Synthesis of a new series of cephalosporins having 3-substituted-ammo-nio-1-propenyl group as the C-3 side chain. J. Antibiot (1990) 43:533–543.
   PubMed Web of Science ®Google Scholar
• LEE JY, LEE YS, SUK DW et al.: Synthesis and biological activity of quaternary ammoniopropenyl cephalospor-ins with hydroxylated alicyclic or aliphatic amines. J. Antibiot. (1996) 49:1286–1289.
   PubMed Web of Science ®Google Scholar
• VVEIDEKAMM E, SCHWEIZER J, JOUBERT P, MCCELLAND G: Pharmacokinetics and safety of the new pare nteral cephalosporin Ro 25–6833. 7th International Conference on Infective Diseases. Hong Kong (1996).
   Google Scholar
• HOHL P, ANGEHRN P, PFLIEGER PH et al.: Comparative activity of the novelvinyl-pyrrolidinone ce phalosporin Ro-48-8391 singly and in combination with the 2 novel bridged carbacephem B-lactarnases inhibitors Ro 48–5545 and Ro 48–8724. 36th Interscience Conference on Antimicrobial Agents and Chemotherapy New Orleans (1996):F144.
   Google Scholar
• SINGH R, SINGH MP, SPEVAK P, MAITI SN, MICETICH RG: New classes of cephalosporins. Oxidation studie s of the 3-heteroarylthiomethylcephems. 28th Intel-science Con-ference of Antimicrobial Agents and Chemotherapy. Los Angeles (1988). Abstract 425.
   Google Scholar
• SINGH MP, SINGH R, MAITI SN et al.: Synthesis and in vitro antimicrobial activity of 3-heteroarylsulphonyl- methyl cephems: a new class of cephalosporins. Eur. J. Med. Chem. (1995) 30:157–164.
   Web of Science ®Google Scholar
• CASE L, CHO IS, CRASE J et al.: Discovery of MC-02, 306 and analogues, new cephalosporins active against re-sistant Gram-positive organisms. 35th Intel-science Con-ference on Antimicrobial Agents and Chemotherapy San Francisco (1995):F48.
   Google Scholar
• CHO IS, GLINKA TS, PRICE Metal.: Discovery of MC 02,831 and analogues, new cephalosporins active against re-sistant Gram-positive organisms. 36th Intel-science Con-ference on Antimicrobial Agents and Chemotherapy. New Orleans (1996):F158.
   Google Scholar
• MALOUIN F, BOND S, CHAN C et al.: In vitro inhibitory activity of a new cephalosporin (MC 02,331) against multi-resistant Gram-positive bacteria. 36th Intel-science Conference ofriAntimicrobial Agents and Chemotherapy. New Orleans (1990E139.
   Google Scholar
• BLAIS J, MALOUIN F, CHAMBERLAND S, LEES: Bactericidal activity and post-antibiotic effect of MC 02,331, a new cephalosporin with potent activity against multi-resis-tant Gram-positive bacteria. 36th Intel-science Conference on Antimicrobial Agents and Chemotherapy New Orleans (1996):F140.
   Google Scholar
• CHAMBERLAND S, BLAIS J, MATHIAS KM et al: MC 02,331, a new cephalosporin with high affinity for PBP2 and stability to staphylococcal B-lactamase. 36th Intel-science Conference on Antimicrobial Agent Chemotherapy. New Orleans (1996):F141.
   Google Scholar
• GRIFFITH D, ANNAMALAI T, BOND SM et al.: In vivo pharmacology of MC 02,331 a new cephalosporin active against multi-resistant Gram-positive organisms. 36th Intel-science Conference of Antimicrobial Agent and Chemo-therapy. New Orleans (1996):F142.
   Google Scholar
• HANAKI N, AKAGI H, YASUI M, OTANI T: Structure-activ-ity relationship of 2-thio isocephem against methicillin-resistant S. aureus.J. Antibiot (1994) 39:901–903.
   Google Scholar
• TSUBOUCHI H, TSUJI K, YASUMURA K, ISHIKAWA H: Synthesis and antibacterial activity of 2-oxa iso-cephems. Chem. Pharm. Bull. (1994) 42:2084–2089.
   PubMed Web of Science ®Google Scholar
• TSUBOUCHI H, ISHIKAWA H: Synthesis and biological properties of a series of optcally active 2-oxaiso-cephems. Bioorg. Med. Chem. (1995) 3:143–150.
   PubMed Web of Science ®Google Scholar
• COOPER RDG, PRESTON DA: The carbacephems. Exp. Opin. Invest. Drugs. (1994) 3:831–848.
   Google Scholar
• TERNANSKY RJ, JORDAN CL, ENDALY JA, KASHER S: Syn-thesis and anti-anaerobic activity of novel 1-carba-1-de-thia cephalosporins. J. Med. Chem. (1993) 36:2332–2334.
   PubMed Web of Science ®Google Scholar
• TERNANSKY RJ, DRAHEIM SE, DIKE AJ et al.: Discovery and structure-activity relationships of a series of 1-carba-1-dethiacephems exhibiting methicillin-resis-tant Staphylococcus aureus. J. Med Chem. (1993) 36:1971–1976.
   PubMed Web of Science ®Google Scholar
• ANGEHRN P, HEINZE-KRAUSS I, HOHL P, WEI CC: Paren-teral cephalosporin Ro 25–6833. Antibacterial activity and spectrum in vitro and in viva 36th Interscience Conference ofAntimicrobial Agents and Chemotherapy. San Francisco (1995):F55.
   Google Scholar